Siemens Healthineers Stock Struggles Amid Major Shareholder Shake-Up
The spin-off involves Siemens AG distributing roughly 30% of its Siemens Healthineers shares to its shareholders. This direct transfer will shrink the parent company’s holding from approximately three-quarters to below 50%, reducing its influence. Investors, however, are wary of the potential flood of new shares entering the market, which has kept demand subdued.
The stock has struggled despite a recent partnership with Rheinmetall to supply CT and X-ray systems for mobile field hospitals. Analysts at Deutsche Bank have assigned a 'Hold' rating with a €46.00 target, pointing to the upcoming share placement as a barrier to short-term growth. JPMorgan, on the other hand, maintains an 'Overweight' stance with a €61.30 target, highlighting strengths in new angiography technology and AI-driven healthcare solutions.
For now, the share price lingers around €43, down nearly 15% since the start of the year. The uncertainty over how many new shares will become available has left buyers hesitant, delaying any meaningful recovery.
The spin-off will reshape Siemens AG’s involvement in Siemens Healthineers, leaving it with a minority stake. Analysts remain divided on the stock’s outlook, with near-term pressure expected from the share distribution. The company’s strategic moves, including its Rheinmetall collaboration, will be closely watched as the market adjusts to the new ownership structure.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
- Inspired & Paddy Power Extend Virtual Sports Partnership for UK & Ireland Retail
- South West & South East England: Check & Object to Lorry Operator Licensing Now
